Our Extensive Intellectual Property Profile

Verenium owns numerous patents covering the compositions of our novel enzyme products and product candidates, as well as their use in the industry. As of March 31, 2012, Verenium owned 203 issued patents and 172 patents pending. In addition, Verenium utilizes and offers services under a licensed, robust intellectual property portfolio with patents covering key technologies in the discovery, optimization, production and use of novel protein-based products. Verenium continues to develop new products and technologies.


As of March 31, 2012, Verenium owned 203 issued patents and 172 patents pending.
    CONTACT US